What are the risks and recovery expectations for Vedolizumab therapy?

Common side effects include nasopharyngitis, headache, arthralgia, and infusion-related reactions (e.g., rash, pruritus). Serious but rare risks include infections, liver injury, and hypersensitivity reactions. Recovery is minimal as the infusion is outpatient-based; most patients resume normal activities immediately after the session. Long-term monitoring for infections is recommended, and you should report any new or worsening symptoms to your healthcare provider.